04:53 PM EDT, 10/25/2024 (MT Newswires) -- Bioventus ( BVS ) filed a registration statement Friday for the potential sale of up to $200 million of securities from time to time.

The filing covers the sale of the company's class A common stock, preferred stock, debt securities, warrants and units.

The company said certain selling shareholders may offer up to 35 million class A common shares, and Bioventus ( BVS ) won't receive any proceeds from the sale.

Shares of the company fell 1.3% in recent after-hours trading.

Price: 13.04, Change: -0.17, Percent Change: -1.29